Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models. Rouanne M, Chen N, Mariuzza DL, Yang Z, et al. Sci Transl Med 2026;18:eadv7600.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rouanne M, Chen N, Mariuzza DL, Yang Z, et al. Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models. Sci Transl Med 2026;18:eadv7600.
PMID: 42485436